Becle S.A.B. de C.V (CUERVO)
Mexican Exchange · Mexico · prices in MXN · close of 22 Oct 2026
Key indicators
| Last close | MXN 16.31 |
|---|---|
| 52-week range | 13.07 – 25.29 |
| Return, 1 month / 3 months | +13.0% / +12.2% |
| Return, 1 year / 3 years | −20.2% / −57.1% |
| Trend | Uptrend |
| RSI (14) | 77 |
| Volatility (1 year) | 30.3% |
| Worst drawdown (1 year) | -43.9% |
| Average daily value traded | 23.12M MXN |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Becle is a Mexican spirits producer based in Mexico City, known for making and marketing tequila under the Jose Cuervo name along with other tequila and mezcal brands, and it also offers whiskey and vodka through its portfolio. The company distills and bottles these spirits and distributes them to bars, restaurants, retailers and consumers in Mexico and in export markets around the world, with a business built on agave-based drinks and other alcoholic beverages.
Becle S.A.B. de C.V trades under the code CUERVO on the Mexican Exchange in Mexico, with its price quoted in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Becle S.A.B. de C.V (CUERVO) trades on the Mexican Exchange in Mexico. It last closed at MXN 16.31 on 22 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 224 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.2% and over the last three months it rose 12.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 30 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 5.6% | ||
| From 52-week high | -33.3% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 12.2% | ||
| 6-month return | 11.8% | ||
| 12-month return, skipping the last month | -29.4% | ||
| Stability (higher is calmer) | 32 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -43.9% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 23.12M MXN | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +11.5% |
|---|---|
| 1 month | +13.0% |
| 3 months | +12.2% |
| 6 months | +11.8% |
| 1 year | −20.2% |
| 3 years | −57.1% |
| 5 years | −58.8% |
Signals
| 50-day / 200-day average | 14.56 / 15.45 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.47 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 May 2026 | MXN 0.5446 |
| 7 May 2025 | MXN 0.3972 |
| 5 Aug 2024 | MXN 0.3954 |
| 1 Aug 2023 | MXN 0.4913 |
| 2 Aug 2022 | MXN 0.4205 |
| 3 Aug 2021 | MXN 0.4304 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.